Article ID Journal Published Year Pages File Type
2159194 Radiotherapy and Oncology 2010 6 Pages PDF
Abstract
After SBRT using RapidArc in lung tumors >80 cm3, the contralateral lung V5 best predicts RP. Limiting contralateral lung V5 to <26% may reduce acute toxicity.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity
Authors
, , , , ,